The National Health Research Ethics Committee, Nigeria, has approved the use of an experimental Ebola drug, Zmapp, for treatment of patients infected with the virus.

The National Health Research Ethics Committee, Nigeria, has approved the use of an experimental Ebola drug, Zmapp, for treatment of patients infected with the virus.  

The decision by the committee is coming on the heels of yesterday’s approval by the World Health Organisation (WHO) on the use of Zmapp for treatment of Ebola patients